AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
TREATMENT EFFECTS ON SERUM-LIPOPROTEIN LIPIDS, APOLIPOPROTEINS AND LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND RELATIONSHIPS OF LIPOPROTEIN VARIABLES TO PROGRESSION OF CORONARY-ARTERY DISEASE IN THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT)
Authors: RUOTOLO G ERICSSON CG TETTAMANTI C KARPE F GRIP L SVANE B NILSSON J DEFAIRE U HAMSTEN A
Citation: G. Ruotolo et al., TREATMENT EFFECTS ON SERUM-LIPOPROTEIN LIPIDS, APOLIPOPROTEINS AND LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND RELATIONSHIPS OF LIPOPROTEIN VARIABLES TO PROGRESSION OF CORONARY-ARTERY DISEASE IN THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), Journal of the American College of Cardiology, 32(6), 1998, pp. 1648-1656
INTERIM ANALYSIS OF THE OPTIMIZATION WITH ICUS TO REDUCE STENT RESTENOSIS (OPTICUS) TRIAL
Authors: MUDRA H MACAYA C ZAHN R GRIP L DIMARIO C RUTSCH W VOUDRIS V SCHACHINGER V HENNEKE KH
Citation: H. Mudra et al., INTERIM ANALYSIS OF THE OPTIMIZATION WITH ICUS TO REDUCE STENT RESTENOSIS (OPTICUS) TRIAL, Circulation, 98(17), 1998, pp. 1908-1908
BEZAFIBRATE FOLLOWING ACUTE MYOCARDIAL-INFARCTION - IMPORTANT FINDINGS FROM THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL
Authors: NILSSON J ERICSSON CG HAMSTEN A GRIP L SVANE B DEFAIRE U
Citation: J. Nilsson et al., BEZAFIBRATE FOLLOWING ACUTE MYOCARDIAL-INFARCTION - IMPORTANT FINDINGS FROM THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL, Fibrinolysis & proteolysis, 11, 1997, pp. 159-162
RETARDATION OF CORONARY ATHEROSCLEROSIS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT) AND OTHER ANGIOGRAPHIC TRIALS
Authors: DEFAIRE U ERICSSON CG GRIP L NILSSON J SVANE B HAMSTEN A
Citation: U. Defaire et al., RETARDATION OF CORONARY ATHEROSCLEROSIS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT) AND OTHER ANGIOGRAPHIC TRIALS, Cardiovascular drugs and therapy, 11, 1997, pp. 257-263
REACTIVATION AFTER CESSATION OF THROMBIN INHIBITION IN UNSTABLE CORONARY-ARTERY DISEASE OCCURS REGARDLESS OF ASPIRIN DOSE
Authors: OLDGREN J GRIP L SIEGBAHN A WALLENTIN L
Citation: J. Oldgren et al., REACTIVATION AFTER CESSATION OF THROMBIN INHIBITION IN UNSTABLE CORONARY-ARTERY DISEASE OCCURS REGARDLESS OF ASPIRIN DOSE, Thrombosis and haemostasis, 1997, pp. 2016-2016
EFFECT OF THROMBIN INHIBITORS ON ACTIVATED PROTEIN-C
Authors: LINDER R BLOMBACK M EGBERG N GRIP L
Citation: R. Linder et al., EFFECT OF THROMBIN INHIBITORS ON ACTIVATED PROTEIN-C, Thrombosis and haemostasis, 1997, pp. 2388-2388
INOGATRAN INHIBITS THROMBIN GENERATION AND FIBRIN TURNOVER MORE EFFECTIVELY THAN HEPARIN IN PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE
Authors: LINDER R OLDGREN J EGBERG N GRIP L LARSON G SIEGBAHN A WALLENTIN L
Citation: R. Linder et al., INOGATRAN INHIBITS THROMBIN GENERATION AND FIBRIN TURNOVER MORE EFFECTIVELY THAN HEPARIN IN PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 2390-2390
LOCAL-DELIVERY OF ANTITHROMBIN-III INHIBITS PLATELET DEPOSITION AFTERBALLOON INJURY IN THE CORONARY-ARTERY IN PIG
Authors: SCHERSTEN F BJORNHEDEN T EMANUELSSON H WIKLUND O GRIP L
Citation: F. Schersten et al., LOCAL-DELIVERY OF ANTITHROMBIN-III INHIBITS PLATELET DEPOSITION AFTERBALLOON INJURY IN THE CORONARY-ARTERY IN PIG, Thrombosis and haemostasis, 1997, pp. 2793-2793
A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
ANTITHROMBIN-III SUPPLEMENTATION FOR PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS - A CONTROLLED RANDOMIZED DOUBLE-BLIND PILOT-STUDY
Authors: GRIP L BLOMBACK M EGBERG N OLSSON A SVANE B VELANDER M
Citation: L. Grip et al., ANTITHROMBIN-III SUPPLEMENTATION FOR PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS - A CONTROLLED RANDOMIZED DOUBLE-BLIND PILOT-STUDY, European heart journal, 18(3), 1997, pp. 443-449
EARLY CORONARY PATENCY EVALUATION OF A PLATELET GLYCOPROTEIN RECEPTORANTAGONIST (ABCIXIMAB) IN PRIMARY PTCA - THE GRAPE-PILOT STUDY
Authors: MERKHOFVANDEN LFM LIEM A ZIJLSTRA F OLSSON H NILSSON H GRIP L VEEN G DEZWAAN C BAR FW VANDERZWAAN C SIMOONS ML VERHEUGT FWA
Citation: Lfm. Merkhofvanden et al., EARLY CORONARY PATENCY EVALUATION OF A PLATELET GLYCOPROTEIN RECEPTORANTAGONIST (ABCIXIMAB) IN PRIMARY PTCA - THE GRAPE-PILOT STUDY, Circulation, 96(8), 1997, pp. 2648-2648
EFFECT OF BEZAFIBRATE TREATMENT OVER 5 YEARS ON CORONARY PLAQUES CAUSING 20-PERCENT TO 50-PERCENT DIAMETER NARROWING (THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL [BECAIT])
Authors: ERICSSON CG NILSSON J GRIP L SVANE B HAMSTEN A
Citation: Cg. Ericsson et al., EFFECT OF BEZAFIBRATE TREATMENT OVER 5 YEARS ON CORONARY PLAQUES CAUSING 20-PERCENT TO 50-PERCENT DIAMETER NARROWING (THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL [BECAIT]), The American journal of cardiology, 80(9), 1997, pp. 1125-1129
CORONARY ANGIOPLASTY IN PATIENTS WITH UNSTABLE ANGINA, WITH SPECIAL REFERENCE TO PRECEDING TREATMENT WITH ANTITHROMBIN-III AND HEPARIN
Authors: GRIP L HELLEKANT C HERZFELD I MALMBERG K SVANE B SZAMOSI A VELANDER M RYDEN L
Citation: L. Grip et al., CORONARY ANGIOPLASTY IN PATIENTS WITH UNSTABLE ANGINA, WITH SPECIAL REFERENCE TO PRECEDING TREATMENT WITH ANTITHROMBIN-III AND HEPARIN, Clinical and applied thrombosis/hemostasis, 2(2), 1996, pp. 107-115
THROMBIN INHIBITION WITH INOGATRAN FOR UNSTABLE ANGINA-PECTORIS - EVIDENCE FOR REACTIVATED ISCHEMIA AFTER CESSATION OF SHORT-TERM TREATMENT
Authors: ANDERSEN K DELLBORG M EMANUELSSON H GRIP L SWEDBERG K
Citation: K. Andersen et al., THROMBIN INHIBITION WITH INOGATRAN FOR UNSTABLE ANGINA-PECTORIS - EVIDENCE FOR REACTIVATED ISCHEMIA AFTER CESSATION OF SHORT-TERM TREATMENT, Coronary artery disease, 7(9), 1996, pp. 673-681
SECONDARY PREVENTIVE POTENTIAL OF LIPID-LOWERING DRUGS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT)
Authors: DEFAIRE U ERICSSON CG GRIP L NILSSON J SVANE B HAMSTEN A
Citation: U. Defaire et al., SECONDARY PREVENTIVE POTENTIAL OF LIPID-LOWERING DRUGS - THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), European heart journal, 17, 1996, pp. 37-42
ANGIOGRAPHIC ASSESSMENT OF EFFECTS OF BEZAFIBRATE ON PROGRESSION OF CORONARY-ARTERY DISEASE IN YOUNG MALE POSTINFARCTION PATIENTS
Authors: ERICSSON CG HAMSTEN A NILSSON J GRIP L SVANE B DEFAIRE U
Citation: Cg. Ericsson et al., ANGIOGRAPHIC ASSESSMENT OF EFFECTS OF BEZAFIBRATE ON PROGRESSION OF CORONARY-ARTERY DISEASE IN YOUNG MALE POSTINFARCTION PATIENTS, Lancet, 347(9005), 1996, pp. 849-853
BEDSIDE HEPARIN MONITORING BY ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURED WITH A DRY REAGENT
Authors: LINDER R GRIP L OLASON E BLOMBACK M
Citation: R. Linder et al., BEDSIDE HEPARIN MONITORING BY ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASURED WITH A DRY REAGENT, Clinical chemistry, 42(9), 1996, pp. 1488-1489
A LOW-MOLECULAR-WEIGHT, SPECIFIC THROMBIN INHIBITOR, INOGATRAN, VERSUS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE
Authors: GRIP L WALLENTIN L DELLBORG M PEER G HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SPECIFIC THROMBIN INHIBITOR, INOGATRAN, VERSUS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE, Circulation, 94(8), 1996, pp. 2512-2512
VARIABLE INHIBITION OF COAGULATION ACTIVITY DURING AND AFTER HEPARIN INFUSION IN PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE
Authors: OLDGREN J LINDER R EGBERG N GRIP L LARSSON G SIEGBAHN A WALLENTIN L
Citation: J. Oldgren et al., VARIABLE INHIBITION OF COAGULATION ACTIVITY DURING AND AFTER HEPARIN INFUSION IN PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE, Circulation, 94(8), 1996, pp. 2513-2513
REACTIVATION AFTER CESSATION OF THROMBIN INHIBITION IN UNSTABLE CORONARY-ARTERY DISEASE OCCURS REGARDLESS OF ASPIRIN DOSE
Authors: OLDGREN J GRIP L WALLENTIN L
Citation: J. Oldgren et al., REACTIVATION AFTER CESSATION OF THROMBIN INHIBITION IN UNSTABLE CORONARY-ARTERY DISEASE OCCURS REGARDLESS OF ASPIRIN DOSE, Circulation, 94(8), 1996, pp. 2515-2515
BEZAFIBRATE RETARDS THE PROGRESSION OF CORONARY ATHEROSCLEROSIS MAINLY IN MILD-TO-MODERATE LESIONS - RESULTS OF FURTHER ANALYSES OF THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT)
Authors: ERICSSON CG DEFAIRE U GRIP L HAMSTEN A NILSSON J SVANE B
Citation: Cg. Ericsson et al., BEZAFIBRATE RETARDS THE PROGRESSION OF CORONARY ATHEROSCLEROSIS MAINLY IN MILD-TO-MODERATE LESIONS - RESULTS OF FURTHER ANALYSES OF THE BEZAFIBRATE CORONARY ATHEROSCLEROSIS INTERVENTION TRIAL (BECAIT), Circulation, 94(8), 1996, pp. 3417-3417
ANTITHROMBOTIC ACTIVITY OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, IN A CLOSED-CHEST PORCINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: URIUDA Y WANG QD GRIP L RYDEN L SJOQUIST PO MATTSSON C
Citation: Y. Uriuda et al., ANTITHROMBOTIC ACTIVITY OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, IN A CLOSED-CHEST PORCINE MODEL OF CORONARY-ARTERY THROMBOSIS, Cardiovascular Research, 32(2), 1996, pp. 320-327
ANTITHROMBIN(III) SUPPLEMENTATION TO PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS
Authors: GRIP L BLOMBACK M EGBERG N OLSSON A SVANE B VELANDER M
Citation: L. Grip et al., ANTITHROMBIN(III) SUPPLEMENTATION TO PATIENTS UNDERGOING PTCA FOR UNSTABLE ANGINA-PECTORIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1250-1250
EXERCISE AND REDISTRIBUTION TL-201 MYOCARDIAL SCINTIGRAPHY - CHANGES IN DISTRIBUTION QUALITATIVELY UNAFFECTED BY PREVIOUS INFARCTION
Authors: GRIP L BONE D SVANE B HOLMGREN A
Citation: L. Grip et al., EXERCISE AND REDISTRIBUTION TL-201 MYOCARDIAL SCINTIGRAPHY - CHANGES IN DISTRIBUTION QUALITATIVELY UNAFFECTED BY PREVIOUS INFARCTION, Clinical physiology, 14(3), 1994, pp. 235-250
INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
Authors: APPLEBY P BAIGENT C COLLINS R FLATHER M PARISH S PETO R BELL P HALLS H MEAD G DIAZ R PAOLASSO E PAVIOTTI C ROMERO G CAMPBELL T OROURKE MF THOMPSON P LESAFFRE E VANDEWERF F VERSTRAETE M ARMSTRONG PW CAIRNS JA MORAN C TURPIE AG YUSUF S GRANDE P HEIKKILA J KALA R BASSAND JP BOISSEL JP BROCHIER M LEIZOROVICZ A BRUGGEMANN T KARSCH KR KASPER W LAMMERTS D NEUHAUS KL MEYER J SCHRODER R VONESSEN R SARAN RK ARDISSINO D BONADUCE D BRUNELLI C CERNIGLIARO C FORESTI A FRANZOSI MG GUIDUCCI D MAGGIONI A MAGNANI B MATTIOLI G ROSSI P SAONTRO E TOGNONI G VISANI L ZENNARO RG KANEMOTO N KAWAI C ARNOLD AER BAR FW SIMOONS ML VERHEUGT FWA VERMEER F WHITE HD SEABRAGOMES R FIGUERAS J LOPEZSENDON J GRIP L HERLITZ J KARLSSON JE WALLENTIN L MONNIER P ADAMS PC BEEN M CHAMBERLAIN DA DEBONO D DOLL R DUFF D FOX KAA SREEHARAN N HILLIS WS JULIAN DG MALCOLM A MURRAY RG PATTERSON DLH POCOCK S REID DS SANDERCOCK P SIGWART U SKELDING J SKENE A SLEIGHT P TIMMIS A WARLOW C WILCOX RG ALLEN A ANDERSON J BRAUNWALD E CALIFF R GOLD HK GRANETT J GRAINGER C GUERCI AD HENNEKENS C HONAN MB KENNEDY JW KNATTERUD G LEE K LEIMBERGER J LENERT LA LITTLEJOHN J MAYNARD C NICKLAS J OHMAN M OLSON HG PASSAMANI E RYAN TJ SELKER HP STUMP D TOPOL EJ WEAVER WD WILLIAMS DO WOODLIEF L
Citation: P. Appleby et al., INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS, Lancet, 343(8893), 1994, pp. 311-322
Risultati: 1-25 | 26-26